6.865
0.29%
-0.015
전일 마감가:
$6.88
열려 있는:
$6.89
하루 거래량:
1.71M
Relative Volume:
0.70
시가총액:
$1.87B
수익:
$248.37M
순이익/손실:
$11.74M
주가수익비율:
-36.13
EPS:
-0.19
순현금흐름:
$18.24M
1주 성능:
-2.28%
1개월 성능:
+3.63%
6개월 성능:
+44.73%
1년 성능:
+84.91%
맨카인드 Stock (MNKD) Company Profile
명칭
Mannkind Corp
전화
818-661-5000
주소
1 CASPER STREET, DANBURY, CA
MNKD을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
MNKD | 6.865 | 1.87B | 248.37M | 11.74M | 18.24M | -0.19 |
VRTX | 450.43 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 749.43 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 589.59 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 246.65 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 106.86 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
맨카인드 Stock (MNKD) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-10-10 | 개시 | Wedbush | Outperform |
2021-05-14 | 개시 | RBC Capital Mkts | Sector Perform |
2019-12-24 | 개시 | Oppenheimer | Outperform |
2019-10-25 | 개시 | Cantor Fitzgerald | Overweight |
2019-05-14 | 개시 | BTIG Research | Buy |
2019-03-04 | 개시 | SVB Leerink | Outperform |
2019-02-22 | 개시 | SVB Leerink | Outperform |
2018-02-28 | 다운그레이드 | Maxim Group | Hold → Sell |
2017-11-01 | 다운그레이드 | Maxim Group | Buy → Hold |
2017-10-10 | 개시 | H.C. Wainwright | Buy |
2017-10-06 | 재확인 | Maxim Group | Buy |
2017-08-11 | 개시 | Maxim Group | Buy |
2016-05-10 | 재확인 | Piper Jaffray | Underweight |
2016-05-10 | 재확인 | RBC Capital Mkts | Underperform |
2016-01-06 | 재확인 | Piper Jaffray | Underweight |
2016-01-06 | 재확인 | RBC Capital Mkts | Underperform |
2015-11-04 | 다운그레이드 | RBC Capital Mkts | Outperform → Underperform |
2015-09-09 | 다운그레이드 | Piper Jaffray | Neutral → Underweight |
2015-08-03 | 재확인 | RBC Capital Mkts | Outperform |
2015-05-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2015-05-11 | 재확인 | MLV & Co | Hold |
2015-04-16 | 재확인 | RBC Capital Mkts | Outperform |
모두보기
맨카인드 주식(MNKD)의 최신 뉴스
MannKind (STU:NNFN) Inventories, Raw Materials & Components : €5.8 Mil (As of Sep. 2024) - GuruFocus.com
MannKind Shares Soar to Over 8-Year Highs on United Therapeutics’ Tyvaso Revenue Surge: Retail Is Optimistic - MSN
MannKind Corp director Steven Binder sells $456,563 in stock - Investing.com
Insulin Pump Market Report 2024-2035, Featuring Profiles of Leading Players Including Beta Bionics, CeQur, EOFlow, Insulet, LA Roche, MannKind, Medtronic, Medtrum Technologies and MicroPort - Yahoo Finance
MannKind Corporation (NASDAQ:MNKD) Q3 2024 Earnings Call Transcript - Insider Monkey
MannKind Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Insider Sale: Chief People & Workpl Officer Stuart Tross Sells 5 - GuruFocus.com
MannKind Corp's chief people officer Stuart Tross sells $403,700 in stock - Investing.com Australia
Earnings call: MannKind sees growth and pipeline progress in Q3 2024 - Investing.com
MannKind Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Pulmatrix Announces Third Quarter 2024 Financial Results and Provides Corporate Update - Quantisnow
MannKind Corp (MNKD) Q3 2024 Earnings Call Highlights: Strong Re - GuruFocus.com
MannKind Corp (MNKD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
MannKind (MNKD) Q3 2024 Earnings Call Transcript - Yahoo! Voices
MannKind (MNKD) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
MannKind Corp Q3 2024 Earnings: EPS of $0.04 Beats Estimates, Re - GuruFocus.com
MannKind (MNKD) Matches Q3 Earnings Estimates - Yahoo Finance
MannKind: Q3 Earnings Snapshot - Thehour.com
MannKind stock soars to 52-week high, hits $7.38 - Investing.com
MannKind Corp (MNKD) Q3 2024 Earnings Report Preview: What To Lo - GuruFocus.com
MannKind Corp (MNKD) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance
International Assets Investment Management LLC Raises Position in MannKind Co. (NASDAQ:MNKD) - MarketBeat
MannKind (NASDAQ:MNKD) Reaches New 1-Year HighWhat's Next? - MarketBeat
MannKind Stock Surge Pre-Market Fueled by Promising Nintedanib DPI Trial Results, Driving Retail Optimism - Barchart
Creative Planning Reduces Position in MannKind Co. (NASDAQ:MNKD) - Defense World
MannKind Corporation (MNKD) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease - ForexTV.com
MannKind (NASDAQ:MNKD) Sets New 1-Year HighTime to Buy? - MarketBeat
MannKind stock soars to 52-week high, touches $6.93 - Investing.com
MannKind Co. (NASDAQ:MNKD) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
MannKind Corporation Reports 2012 Fourth Quarter and Full Year Financial Results - AOL
SG Americas Securities LLC Takes Position in MannKind Co. (NASDAQ:MNKD) - MarketBeat
Mannkind Corp (MNKD) receives an Outperform rating from Leerink Partners - Knox Daily
Recent Insider Activity Could Benefit 3M Co. (MMM) - Knox Daily
Holdings of Mannkind Corp (MNKD) are aligned with the stars - SETE News
Selling Buzz: Mannkind Corp [MNKD] Chief People & Workpl Officer Tross Stuart A sells 25,000 shares of the company - Knox Daily
Ratios Revealed: Decoding Mannkind Corp (MNKD)’s Financial Health - The Dwinnex
MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Pipeline ... By GuruFocus - Investing.com Canada
MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Pipeline ... - Yahoo Finance
MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Re - GuruFocus.com
Did Mannkind Corp (MNKD) perform well in the last session? - US Post News
Potential Price Increase for Mannkind Corp (MNKD) After Recent Insider Activity - Knox Daily
Mannkind Corp (MNKD) can make a big difference with a little luck - SETE News
Squarepoint Ops LLC Sells 133,926 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
Why MannKind (MNKD) Could Beat Earnings Estimates Again - Yahoo Finance
MannKind (MNKD) Just Overtook the 20-Day Moving Average - Yahoo Finance
MannKind Co. (NASDAQ:MNKD) Shares Purchased by Millennium Management LLC - MarketBeat
MannKind (NASDAQ:MNKD) Shares Up 3.2% - MarketBeat
MannKind Leverages Tyvaso DPI Strength In Pulmonary Market Expansion - Seeking Alpha
Marshall Wace LLP Sells 205,764 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
A better buy-in window may exist right now for Mannkind Corp (MNKD) - SETE News
맨카인드 (MNKD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):